
Enzo Biochem ENZ
Quarterly report 2024-Q3
added 12-16-2024
Enzo Biochem Operating Cycle 2011-2026 | ENZ
Annual Operating Cycle Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 206 | 235 | 294 | 88.1 | 102 | 97.7 | 89.8 | 94.6 | 96.3 | 119 | 106 | 106 | 107 | 117 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 294 | 88.1 | 133 |
Quarterly Operating Cycle Enzo Biochem
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 221 | - | 212 | 212 | 215 | - | 449 | 456 | 458 | 21.8 | 110 | 99.1 | 117 | 51.1 | 81.5 | 102 | 77.2 | 46.4 | 74.8 | 97.5 | 95 | 49.2 | 109 | 91.1 | 103 | 44 | 107 | 51.8 | 91 | 26.4 | 47.3 | 50 | 49.7 | 26.8 | 45.8 | 48.5 | 45.1 | 23.1 | 43.4 | 48.2 | 45.7 | 24.2 | 46 | 54 | 49.2 | 23.4 | 48.6 | 50.1 | 50.1 | 25.4 | 25.2 | 28.2 | 53 | 28.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 458 | 21.8 | 93.3 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Anixa Biosciences
ANIX
|
275 | $ 3.11 | 0.32 % | $ 101 K | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 33.47 | -0.21 % | $ 360 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
329 | $ 1.49 | 1.36 % | $ 1.89 M | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 39.19 | 0.07 % | $ 1.09 B | ||
|
Co-Diagnostics
CODX
|
405 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
150 | $ 220.3 | 0.38 % | $ 161 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Exact Sciences Corporation
EXAS
|
269 | $ 102.42 | 0.12 % | $ 19 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 26.19 | -0.19 % | $ 792 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
204 | $ 74.41 | 0.55 % | $ 28.7 B | ||
|
Guardant Health
GH
|
49.1 | $ 114.95 | 4.05 % | $ 14.1 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 20.73 | -0.34 % | $ 1.11 B | ||
|
DarioHealth Corp.
DRIO
|
251 | $ 10.3 | - | $ 292 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
198 | $ 149.13 | -0.37 % | $ 23.7 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Lantheus Holdings
LNTH
|
116 | $ 66.81 | 0.19 % | $ 4.62 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 232.67 | -1.19 % | $ 42.2 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 210.7 | -0.5 % | $ 10.8 B | ||
|
NeoGenomics
NEO
|
103 | $ 12.4 | - | $ 1.57 B | ||
|
Medpace Holdings
MEDP
|
51.5 | $ 589.18 | -0.66 % | $ 18.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
56.9 | $ 185.86 | 1.94 % | $ 20.6 B | ||
|
Biodesix
BDSX
|
41.7 | $ 9.78 | 1.24 % | $ 1.27 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
49.8 | $ 24.39 | 0.54 % | $ 31.7 M | ||
|
Laboratory Corporation of America Holdings
LH
|
72.9 | $ 272.1 | 0.85 % | $ 22.8 B | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 388.7 | -0.3 % | $ 29.5 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 184.66 | -0.66 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
135 | $ 680.0 | 0.49 % | $ 56.1 B | ||
|
Personalis
PSNL
|
55.8 | $ 9.82 | -1.55 % | $ 582 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 28.82 | -1.47 % | $ 20 B | ||
|
Agilent Technologies
A
|
161 | $ 133.03 | -0.16 % | $ 40.4 B | ||
|
Biomerica
BMRA
|
204 | $ 2.35 | -1.67 % | $ 5.4 M |